HLA-G 3′ untranslated region variants +3187G/G, +3196G/G and +3035T define diametrical clinical status and disease outcome in epithelial ovarian cancer-Reference-Cited by-同舟云学术

HLA-G 3′ untranslated region variants +3187G/G, +3196G/G and +3035T define diametrical clinical status and disease outcome in epithelial ovarian cancer

Published:2019-04-01 Issue:1 Volume:9 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Schwich Esther,Rebmann Vera,Michita Rafael Tomoya,Rohn Hana,Voncken Jan Willem,Horn Peter A.,Kimmig Rainer,Kasimir-Bauer Sabine,Buderath Paul

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-019-41900-z.pdf

Reference60 articles.

1. Rebmann, V., da Silva Nardi, F., Wagner, B. & Horn, P. A. HLA-G as a tolerogenic molecule in transplantation and pregnancy. J Immunol Res 2014, 297073, https://doi.org/10.1155/2014/297073 (2014).

2. Amiot, L., Ferrone, S., Grosse-Wilde, H. & Seliger, B. Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention? Cell Mol Life Sci 68, 417–431, https://doi.org/10.1007/s00018-010-0583-4 (2011).

3. Paul, P. et al. Identification of HLA-G 7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. Hum Immunol 61, 1138–1149 (2000).

4. Paul, P. et al. HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. Proc Natl Acad Sci USA 95, 4510–4515 (1998).

5. Carosella, E. D., Paul, P., Moreau, P. & Rouas-Freiss, N. HLA-G and HLA-E: fundamental and pathophysiological aspects. Immunol Today 21, 532–534 (2000).

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peripheral HLA-G/ILT-2 immune checkpoint axis in acute and convalescent COVID-19 patients;Human Immunology;2023-08

2. Elevated sHLA-G plasma levels post chemotherapy combined with ILT-2 rs10416697C allele status of the sHLA-G-related receptor predict poorest disease outcome in early triple-negative breast cancer patients;Frontiers in Immunology;2023-05-22

3. Dimerization of Transmembrane Proteins in Cancer Immunotherapy;Membranes;2023-03-30

4. Evidence for Epistatic Interaction between HLA-G and LILRB1 in the Pathogenesis of Nonsegmental Vitiligo;Cells;2023-02-15

5. Molecular Characterization of Single Circulating Tumor Cells in Breast and Ovarian Cancer;Circulating Tumor Cells;2023